K02

N/A

Report date: 2024/12/18 13:39:48

NME

Base Information

Drug NameK02

Drug Alias NameKO2K11002

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPeptide hydrolase inhibitors

TargetsPeptide hydrolase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCelera Genomics

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCelera Genomics

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A